Breaking News Instant updates and real-time market news.

NBRV

Nabriva Therapeutics

$1.45 /

-0.03 (-2.03%)

, MRK

Merck

$76.97 /

+0.57 (+0.75%)

12:15
04/15/21
04/15
12:15
04/15/21
12:15

Nabriva announces start of exclusive distribution of Sivextro in U.S.

Nabriva Therapeutics (NBRV) announced that it has begun exclusive distribution of Sivextro in the United States. Sivextro is now listed in the National Drug Code Directory under the Nabriva label. Since April 12, 2021, Nabriva has been marketing and distributing Sivextro in the United States and certain of its territories as part of an exclusive agreement signed in July 2020 with subsidiaries of Merck (MRK), the company noted. Under the terms of the agreement with Merck, Nabriva will continue to procure Sivextro from Merck and be solely responsible for marketing, sales, and distribution of Sivextro in the United States at least through December 31, 2023, with renewable three-year extensions. As a result, Nabriva expects to recognize 100% of net product sales of Sivextro in its results of operations beginning on April 12, 2021, the company said.

NBRV

Nabriva Therapeutics

$1.45 /

-0.03 (-2.03%)

MRK

Merck

$76.97 /

+0.57 (+0.75%)

  • 15

    Apr

  • 28

    Apr

  • 29

    Apr

  • 29

    Apr

  • 03

    May

  • 25

    May

  • 18

    Jul

  • 15

    Sep

  • 28

    Nov

  • 21

    Dec

  • 11

    Dec

NBRV Nabriva Therapeutics
$1.45 /

-0.03 (-2.03%)

03/12/21 Northland
Nabriva Therapeutics price target lowered to $6 from $9 at Northland
06/22/20 Northland
Nabriva Therapeutics price target lowered to $1.50 from $2.50 at Northland
04/23/20 Northland
Nabriva Therapeutics price target lowered to $2.50 from $5 at Northland
MRK Merck
$76.97 /

+0.57 (+0.75%)

04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
04/08/21 Alliance Global Partners
Alliance Global Partners sees Fast Track for Immutep efti as meaningful positive
04/08/21 H.C. Wainwright
Alkermes collaboration not as big as investors wanted, says H.C. Wainwright
04/07/21 Mizuho
Mizuho sees Alkermes, Merck collaboration as important next step for nemvaleukin

TODAY'S FREE FLY STORIES

Initiation
Forte Biosciences initiated with a Buy at B. Riley » 21:35
05/13/21
05/13
21:35
05/13/21
21:35
FBRX

Forte Biosciences

$31.75 /

-2.45 (-7.16%)

B. Riley initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FBRX Forte Biosciences
$31.75 /

-2.45 (-7.16%)

03/26/21 Citi
Forte Biosciences initiated with a Buy at Citi
03/17/21 Chardan
Chardan 'blue skies' valuation for Forte yields up to $839 share price
11/11/20 Chardan
Forte Biosciences price target raised to $115 from $110 at Chardan
09/24/20 Chardan
Forte Biosciences price target raised to $110 from $60 at Chardan
FBRX Forte Biosciences
$31.75 /

-2.45 (-7.16%)

  • 29
    Oct
FBRX Forte Biosciences
$31.75 /

-2.45 (-7.16%)

Initiation
Allogene Therapeutics initiated with a Buy at B. Riley » 21:35
05/13/21
05/13
21:35
05/13/21
21:35
ALLO

Allogene Therapeutics

$26.92 /

-1.02 (-3.65%)

B. Riley initiated…

B. Riley initiated coverage of Allogene Therapeutics with a Buy rating and $52 price target.

ShowHide Related Items >><<
ALLO Allogene Therapeutics
$26.92 /

-1.02 (-3.65%)

ALLO Allogene Therapeutics
$26.92 /

-1.02 (-3.65%)

03/01/21 H.C. Wainwright
Allogene Therapeutics price target raised to $43 from $40 at H.C. Wainwright
01/26/21 Stifel
Allogene Therapeutics upgraded to Buy from Hold at Stifel
12/28/20 H.C. Wainwright
SpringsWorks Therapeutics price target raised to $87 from $73 at H.C. Wainwright
12/10/20 H.C. Wainwright
Allogene Therapeutics assumed with a Buy at H.C. Wainwright
ALLO Allogene Therapeutics
$26.92 /

-1.02 (-3.65%)

  • 02
    Jun
Syndicate
Monaker Group 3.23M share Spot Secondary priced at $2.50 » 20:59
05/13/21
05/13
20:59
05/13/21
20:59
MKGI

Monaker Group

$2.94 /

-0.01 (-0.34%)

The deal priced below the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MKGI Monaker Group
$2.94 /

-0.01 (-0.34%)

  • 14
    May
  • 29
    Dec
Syndicate
Vera Therapeutics 4.35M share IPO priced at $11.00 » 20:57
05/13/21
05/13
20:57
05/13/21
20:57
VERA

Vera Therapeutics

/

+

The deal priced below the…

The deal priced below the $14.00-$16.00 range. Jefferies, Cowen and Evercore ISI are acting as joint book running managers for the offering.

ShowHide Related Items >><<
  • 14
    May
Upgrade
Vertex Energy upgraded to Buy from Hold at Stifel » 20:35
05/13/21
05/13
20:35
05/13/21
20:35
VTNR

Vertex Energy

$1.70 /

+0.34 (+25.00%)

Stifel analyst Michael…

Stifel analyst Michael Hoffman upgraded Vertex Energy to Buy from Hold with a $2 price target.

ShowHide Related Items >><<
VTNR Vertex Energy
$1.70 /

+0.34 (+25.00%)

VTNR Vertex Energy
$1.70 /

+0.34 (+25.00%)

02/10/21
Fly Intel: Top five analyst downgrades
02/10/21 Stifel
Stifel downgrades Vertex Energy to Hold on 'lofty' free cash flow expectations
02/09/21 Stifel
Vertex Energy downgraded to Hold from Buy at Stifel
VTNR Vertex Energy
$1.70 /

+0.34 (+25.00%)

General news
Treasury Market Summary » 19:55
05/13/21
05/13
19:55
05/13/21
19:55
$ECON

Economic Data

/

+

Treasury Market Summary:…

Treasury Market Summary: Thursday was a day of correction for bonds and stocks. Treasury yields richened, recovering from Wednesday's big selloff as the market took in stride another hot inflation report, a rally on Wall Street, and a poor 30-year auction. Rates were about 1 to 3 bps lower across the curve, though ended off their intraday lows. The 10-year finished around 1.65%, with the bond at 2.385%, and the 2-year at 0.153%. Wall Street also corrected from oversold conditions with solid gains in major indexes as reflation trades helped lead the advance. The slip in the 10-year yield also supported stocks, along with the drop in jobless claims, were the catalysts for dip buying. The Dow and S&P 500 bounced 1.29% and 1.122%, respectively, and reclaimed the 34k and 4100 handles. The NASDAQ was in the green but lagged with a 0.72% gain. Data included a jump in headline and core PPI rates and a drop in initial jobless claims to the lowest level since the pandemic hit. View the summary.

ShowHide Related Items >><<
    Hot Stocks
    CenterPoint Energy CEO buys 50K shares of common stock » 19:54
    05/13/21
    05/13
    19:54
    05/13/21
    19:54
    CNP

    CenterPoint Energy

    $24.46 /

    +0.82 (+3.47%)

    In a regulatory filing,…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    CNP CenterPoint Energy
    $24.46 /

    +0.82 (+3.47%)

    CNP CenterPoint Energy
    $24.46 /

    +0.82 (+3.47%)

    06:42 Today Mizuho
    CenterPoint Energy price target raised to $27 from $25.50 at Mizuho
    01/21/21 Evercore ISI
    CenterPoint Energy upgraded to Outperform from In Line at Evercore ISI
    01/14/21 Goldman Sachs
    CenterPoint Energy upgraded to Buy from Neutral at Goldman Sachs
    01/06/21 Wells Fargo
    Wells Fargo says buy CenterPoint Energy, sell FirstEnergy
    CNP CenterPoint Energy
    $24.46 /

    +0.82 (+3.47%)

    Hot Stocks
    Biglari CEO buys 20K shares of common stock » 19:52
    05/13/21
    05/13
    19:52
    05/13/21
    19:52
    BH

    Biglari

    $150.88 /

    +2.32 (+1.56%)

    In a regulatory filing,…

    In a regulatory filing, Biglari disclosed that its CEO Sardar Biglari bought 20K shares of common stock on May 11th in a total transaction size of $3.41M, boosting his total stake by about 1%.

    ShowHide Related Items >><<
    BH Biglari
    $150.88 /

    +2.32 (+1.56%)

    Upgrade
    UDG Healthcare upgraded to Hold from Underperform at Jefferies » 19:50
    05/13/21
    05/13
    19:50
    05/13/21
    19:50
    UDHCF

    UDG Healthcare

    $11.63 /

    + (+0.00%)

    Jefferies analyst James…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    UDHCF UDG Healthcare
    $11.63 /

    + (+0.00%)

    06:22 Today Berenberg
    UDG Healthcare downgraded to Hold from Buy at Berenberg
    05/06/21 Barclays
    UDG Healthcare price target raised to 975 GBp from 920 GBp at Barclays
    11/11/20 RBC Capital
    UDG Healthcare upgraded to Outperform from Sector Perform at RBC Capital
    11/09/20 Jefferies
    UDG Healthcare downgraded to Underperform from Hold at Jefferies
    Hot Stocks
    Blink Charging issues going concern notice in 10-Q filing » 19:48
    05/13/21
    05/13
    19:48
    05/13/21
    19:48
    BLNK

    Blink Charging

    $26.18 /

    -2.64 (-9.16%)

    In a regulatory 10-Q…

    In a regulatory 10-Q filing, the company states: "We have experienced substantial net losses, and we expect to continue to incur substantial losses for the foreseeable future. We incurred net losses of approximately $7.4M for the quarter ended March 31, 2021. As of March 31, 2021, we had net working capital of approximately $231M and an accumulated deficit of approximately $195M. We have not yet achieved profitability. These factors raise substantial doubt about our ability to continue as a going concern, as expressed in the notes to our consolidated financial statements. Historically, we have been able to raise funds to support our business operations, although there can be no assurance we will be successful. If our revenue grows slower than we anticipate, or if our operating expenses are higher than we expect, we may not be able to achieve profitability and our financial condition could suffer. We can give no assurance that we will ever achieve profitable operations. Even if we achieve profitability in the future, we may not be able to sustain profitability in subsequent periods. Whether we can achieve cash flow levels sufficient to support our operations cannot be accurately predicted. Unless such cash flow levels are achieved, we may need to borrow additional funds or sell our debt or equity securities, or some combination of both, to provide funding for our operations. Such additional funding may not be available on commercially reasonable terms, or at all."

    ShowHide Related Items >><<
    BLNK Blink Charging
    $26.18 /

    -2.64 (-9.16%)

    BLNK Blink Charging
    $26.18 /

    -2.64 (-9.16%)

    05/11/21
    Fly Intel: Top five analyst initiations
    05/11/21 Needham
    Blink Charging initiated with a Buy at Needham
    05/10/21 Needham
    Blink Charging initiated with a Buy at Needham
    03/08/21 Cowen
    Blink Charging initiated with an Outperform at Cowen
    BLNK Blink Charging
    $26.18 /

    -2.64 (-9.16%)

    • 08
      Jan
    BLNK Blink Charging
    $26.18 /

    -2.64 (-9.16%)

    BLNK Blink Charging
    $26.18 /

    -2.64 (-9.16%)

    BLNK Blink Charging
    $26.18 /

    -2.64 (-9.16%)

    Hot Stocks
    Grupo Comercial Chedraui to acquire Smart & Final for roughly $620M » 19:21
    05/13/21
    05/13
    19:21
    05/13/21
    19:21
    APO

    Apollo Global

    $56.25 /

    +0.48 (+0.86%)

    Grupo Comercial Chedraui…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    APO Apollo Global
    $56.25 /

    +0.48 (+0.86%)

    APO Apollo Global
    $56.25 /

    +0.48 (+0.86%)

    07:01 Today UBS
    Athene Holding downgraded to Neutral from Buy at UBS
    05/10/21 Citi
    Citi boosts Apollo target to $72, opens 'Positive Catalyst Watch'
    05/05/21 Wells Fargo
    Apollo Global price target raised to $65 from $57 at Wells Fargo
    05/05/21 Deutsche Bank
    Apollo Global price target raised to $54 from $49 at Deutsche Bank
    APO Apollo Global
    $56.25 /

    +0.48 (+0.86%)

    APO Apollo Global
    $56.25 /

    +0.48 (+0.86%)

    APO Apollo Global
    $56.25 /

    +0.48 (+0.86%)

    APO Apollo Global
    $56.25 /

    +0.48 (+0.86%)

    Initiation
    Live Nation initiated with an Outperform at Wolfe Research » 18:59
    05/13/21
    05/13
    18:59
    05/13/21
    18:59
    LYV

    Live Nation

    $81.25 /

    +3.31 (+4.25%)

    Wolfe Research analyst…

    Wolfe Research analyst John Janedis initiated coverage of Live Nation with an Outperform rating and $97 price target. The analyst contends that Live Nation is poised for a multi-year cycle of strong growth as re-opening accelerates with added benefits of a favorable supply / demand and a structurally stronger margin profile emerging from the pandemic. Janedis adds that he sees Live Nation as well positioned to grow market share given its scale and vertical positioning in live entertainment.

    ShowHide Related Items >><<
    LYV Live Nation
    $81.25 /

    +3.31 (+4.25%)

    LYV Live Nation
    $81.25 /

    +3.31 (+4.25%)

    17:53 Today Wolfe Research
    Live Nation initiated with an Outperform at Wolfe Research
    05/10/21
    Fly Intel: Top five analyst upgrades
    05/10/21 Jefferies
    Live Nation upgraded to Buy following 13% pullback at Jefferies
    05/10/21 Jefferies
    Live Nation upgraded to Buy from Hold at Jefferies
    LYV Live Nation
    $81.25 /

    +3.31 (+4.25%)

    LYV Live Nation
    $81.25 /

    +3.31 (+4.25%)

    LYV Live Nation
    $81.25 /

    +3.31 (+4.25%)

    LYV Live Nation
    $81.25 /

    +3.31 (+4.25%)

    Hot Stocks
    Elon Musk working with Dogecoin devs to 'improve system transaction efficiency' » 18:57
    05/13/21
    05/13
    18:57
    05/13/21
    18:57
    TSLA

    Tesla

    $571.75 /

    -18.09 (-3.07%)

    , $DOGE

    Dogecoin

    /

    +

    Tesla CEO Elon Musk said…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    TSLA Tesla
    $571.75 /

    -18.09 (-3.07%)

    $DOGE Dogecoin
    /

    +

    TSLA Tesla
    $571.75 /

    -18.09 (-3.07%)

    08:16 Today Wedbush
    Tesla backtracking on crypto transaction 'very surprising,' says Wedbush
    05/12/21 JPMorgan
    JPMorgan says reports on Tesla halting Shanghai expansion are inaccurate
    05/11/21 Piper Sandler
    Piper says 'hard to draw meaningful conclusions' from 'messy' Tesla China data
    05/11/21 Wedbush
    Tesla April China deliveries see some softness, China tensions key, says Wedbush
    $DOGE Dogecoin
    /

    +

    TSLA Tesla
    $571.75 /

    -18.09 (-3.07%)

    TSLA Tesla
    $571.75 /

    -18.09 (-3.07%)

    TSLA Tesla
    $571.75 /

    -18.09 (-3.07%)

    TSLA Tesla
    $571.75 /

    -18.09 (-3.07%)

    Hot Stocks
    Canadian National sees Kansas City Southern deal completion in 2H22 » 18:54
    05/13/21
    05/13
    18:54
    05/13/21
    18:54
    CNI

    Canadian National

    $111.04 /

    +0.25 (+0.23%)

    , KSU

    Kansas City Southern

    $313.41 /

    +7.14 (+2.33%)

    , CP

    Canadian Pacific

    $401.15 /

    +9.24 (+2.36%)

    CN (CNI) said it is…

    CN (CNI) said it is confident in its ability to obtain approval from the Surface Transportation Board and other regulatory bodies on a timeline consistent with the proposed CP (CP) transaction. CN has proposed to use a voting trust and trustee that are identical to those the STB approved for CP's proposed acquisition. KCS (KSU) shareholders will receive the merger consideration immediately upon the closing of CN's voting trust, which is expected to be in the second half of 2021. Moreover, CN's proposed transaction will not require the approval of CN's shareholders, eliminating a closing condition present in the proposed CP transaction and thereby providing greater certainty of closing. The completion of the transaction would be expected to take place in the second half of 2022.

    ShowHide Related Items >><<
    CNI Canadian National
    $111.04 /

    +0.25 (+0.23%)

    CNI Canadian National
    $111.04 /

    +0.25 (+0.23%)

    04/27/21 CIBC
    Canadian National price target lowered to C$146 from C$148 at CIBC
    04/27/21 Wells Fargo
    Canadian National price target raised to $120 from $113 at Wells Fargo
    04/26/21 Susquehanna
    Canadian Pacific will have to raise bid to win KSU war, says Susquehanna
    04/22/21 Credit Suisse
    Canadian Pacific not planning to preemptively raise bid, says Credit Suisse
    KSU Kansas City Southern
    $313.41 /

    +7.14 (+2.33%)

    04/26/21 Deutsche Bank
    Kansas City Southern price target raised to $300 from $212 at Deutsche Bank
    04/22/21 Susquehanna
    Canadian Pacific price target raised to $403 from $402 at Susquehanna
    CP Canadian Pacific
    $401.15 /

    +9.24 (+2.36%)

    04/26/21 Deutsche Bank
    Canadian Pacific price target raised to $405 from $368 at Deutsche Bank
    04/23/21 Desjardins
    Canadian Pacific price target raised to C$529 from C$525 at Desjardins
    04/22/21 National Bank
    Canadian Pacific price target lowered to C$511 from C$515 at National Bank
    KSU Kansas City Southern
    $313.41 /

    +7.14 (+2.33%)

    CP Canadian Pacific
    $401.15 /

    +9.24 (+2.36%)

    CNI Canadian National
    $111.04 /

    +0.25 (+0.23%)

    KSU Kansas City Southern
    $313.41 /

    +7.14 (+2.33%)

    CNI Canadian National
    $111.04 /

    +0.25 (+0.23%)

    CP Canadian Pacific
    $401.15 /

    +9.24 (+2.36%)

    CNI Canadian National
    $111.04 /

    +0.25 (+0.23%)

    KSU Kansas City Southern
    $313.41 /

    +7.14 (+2.33%)

    Hot Stocks
    Canadian National enhances Kansas City Southern proposal to $325 per share » 18:53
    05/13/21
    05/13
    18:53
    05/13/21
    18:53
    CNI

    Canadian National

    $111.04 /

    +0.25 (+0.23%)

    , KSU

    Kansas City Southern

    $313.41 /

    +7.14 (+2.33%)

    , CP

    Canadian Pacific

    $401.15 /

    +9.24 (+2.36%)

    Canadian National (CNI)…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    CP Canadian Pacific
    $401.15 /

    +9.24 (+2.36%)

    CNI Canadian National
    $111.04 /

    +0.25 (+0.23%)

    CNI Canadian National
    $111.04 /

    +0.25 (+0.23%)

    04/27/21 CIBC
    Canadian National price target lowered to C$146 from C$148 at CIBC
    04/27/21 Wells Fargo
    Canadian National price target raised to $120 from $113 at Wells Fargo
    04/26/21 Susquehanna
    Canadian Pacific will have to raise bid to win KSU war, says Susquehanna
    04/22/21 Credit Suisse
    Canadian Pacific not planning to preemptively raise bid, says Credit Suisse
    KSU Kansas City Southern
    $313.41 /

    +7.14 (+2.33%)

    04/26/21 Deutsche Bank
    Kansas City Southern price target raised to $300 from $212 at Deutsche Bank
    04/22/21 Susquehanna
    Canadian Pacific price target raised to $403 from $402 at Susquehanna
    CP Canadian Pacific
    $401.15 /

    +9.24 (+2.36%)

    04/26/21 Deutsche Bank
    Canadian Pacific price target raised to $405 from $368 at Deutsche Bank
    04/23/21 Desjardins
    Canadian Pacific price target raised to C$529 from C$525 at Desjardins
    04/22/21 National Bank
    Canadian Pacific price target lowered to C$511 from C$515 at National Bank
    KSU Kansas City Southern
    $313.41 /

    +7.14 (+2.33%)

    CP Canadian Pacific
    $401.15 /

    +9.24 (+2.36%)

    CNI Canadian National
    $111.04 /

    +0.25 (+0.23%)

    KSU Kansas City Southern
    $313.41 /

    +7.14 (+2.33%)

    CNI Canadian National
    $111.04 /

    +0.25 (+0.23%)

    CP Canadian Pacific
    $401.15 /

    +9.24 (+2.36%)

    CNI Canadian National
    $111.04 /

    +0.25 (+0.23%)

    KSU Kansas City Southern
    $313.41 /

    +7.14 (+2.33%)

    Hot Stocks
    Kansas City Southern receives 'Company Superior Proposal' from Canadian National » 18:25
    05/13/21
    05/13
    18:25
    05/13/21
    18:25
    KSU

    Kansas City Southern

    $313.41 /

    +7.14 (+2.33%)

    , CNI

    Canadian National

    $111.04 /

    +0.25 (+0.23%)

    , CP

    Canadian Pacific

    $401.15 /

    +9.24 (+2.36%)

    Kansas City Southern…

    Kansas City Southern (KSU) announced receipt of a revised acquisition proposal from Canadian National Railway Company (CNI). Under the terms of CN's revised proposal, each share of KCS common stock would be exchanged for $200 in cash and 1.129 shares of CN common stock. The proposal is binding on CN and may be accepted by KCS at any time prior to 5:00 pm EDT on Friday, May 21. The transaction would be subject to approval by the stockholders of KCS, approval by the Surface Transportation Board of a voting trust, receipt of other regulatory approvals and other customary closing conditions. After consultation with the company's outside legal and financial advisors, the KCS board of directors determined that CN's revised proposal constitutes a "Company Superior Proposal" as defined in KCS's merger agreement with Canadian Pacific Railway (CP). KCS has notified CP that it intends to terminate KCS's merger agreement with CP and enter into the definitive agreement with CN, subject to CP's right to negotiate amendments to the merger agreement for at least five business days and the KCS board's further determination as to whether any such amendments would cause the CN proposal no longer to constitute a "Company Superior Proposal."

    ShowHide Related Items >><<
    KSU Kansas City Southern
    $313.41 /

    +7.14 (+2.33%)

    CP Canadian Pacific
    $401.15 /

    +9.24 (+2.36%)

    KSU Kansas City Southern
    $313.41 /

    +7.14 (+2.33%)

    04/26/21 Deutsche Bank
    Kansas City Southern price target raised to $300 from $212 at Deutsche Bank
    04/26/21 Susquehanna
    Canadian Pacific will have to raise bid to win KSU war, says Susquehanna
    04/22/21 Credit Suisse
    Canadian Pacific not planning to preemptively raise bid, says Credit Suisse
    04/22/21 Susquehanna
    Canadian Pacific price target raised to $403 from $402 at Susquehanna
    CNI Canadian National
    $111.04 /

    +0.25 (+0.23%)

    04/27/21 CIBC
    Canadian National price target lowered to C$146 from C$148 at CIBC
    04/27/21 Wells Fargo
    Canadian National price target raised to $120 from $113 at Wells Fargo
    CP Canadian Pacific
    $401.15 /

    +9.24 (+2.36%)

    04/26/21 Deutsche Bank
    Canadian Pacific price target raised to $405 from $368 at Deutsche Bank
    04/23/21 Desjardins
    Canadian Pacific price target raised to C$529 from C$525 at Desjardins
    04/22/21 National Bank
    Canadian Pacific price target lowered to C$511 from C$515 at National Bank
    KSU Kansas City Southern
    $313.41 /

    +7.14 (+2.33%)

    CP Canadian Pacific
    $401.15 /

    +9.24 (+2.36%)

    CNI Canadian National
    $111.04 /

    +0.25 (+0.23%)

    KSU Kansas City Southern
    $313.41 /

    +7.14 (+2.33%)

    CNI Canadian National
    $111.04 /

    +0.25 (+0.23%)

    KSU Kansas City Southern
    $313.41 /

    +7.14 (+2.33%)

    CP Canadian Pacific
    $401.15 /

    +9.24 (+2.36%)

    KSU Kansas City Southern
    $313.41 /

    +7.14 (+2.33%)

    Hot Stocks
    Wesco director Raymund sells nearly 8,000 common shares » 18:24
    05/13/21
    05/13
    18:24
    05/13/21
    18:24
    WCC

    Wesco

    $107.74 /

    +5.755 (+5.64%)

    In a regulatory filing,…

    In a regulatory filing, Wesco director Steven Raymund disclosed the sale of 7,852 common shares of the company on May 11 at a price of $106.69 per share.

    ShowHide Related Items >><<
    WCC Wesco
    $107.74 /

    +5.755 (+5.64%)

    WCC Wesco
    $107.74 /

    +5.755 (+5.64%)

    05/11/21 KeyBanc
    Wesco price target raised to $125 from $96 at KeyBanc
    05/10/21 Oppenheimer
    Wesco price target raised to $125 from $90 at Oppenheimer
    05/07/21 RBC Capital
    Wesco price target raised to $119 from $109 at RBC Capital
    04/05/21 Wells Fargo
    Wesco price target raised to $110 from $90 at Wells Fargo
    WCC Wesco
    $107.74 /

    +5.755 (+5.64%)

    WCC Wesco
    $107.74 /

    +5.755 (+5.64%)

    Periodicals
    Pinterest planning livestream virtual event this month, TechCrunch reports » 18:22
    05/13/21
    05/13
    18:22
    05/13/21
    18:22
    PINS

    Pinterest

    $55.49 /

    -1.635 (-2.86%)

    Pinterest intends to host…

    Pinterest intends to host a three-day virtual live event that will include livestreamed sessions from notable creators, including Jonathan Van Ness and Rebecca Minkoff, TechCrunch's Sarah Perez reports. The event will will run within the Pinterest app from May 24 through May 25, and will serve as Pinterest's first public test of directly streaming creator content to its over 475M users worldwide, Perez says. Reference Link

    ShowHide Related Items >><<
    PINS Pinterest
    $55.49 /

    -1.635 (-2.86%)

    PINS Pinterest
    $55.49 /

    -1.635 (-2.86%)

    05/10/21 Arete
    Pinterest initiated with a Buy at Arete
    05/10/21 Citi
    Pinterest price target lowered to $65 from $85 at Citi
    04/30/21 MKM Partners
    Twitter price target lowered to $83 from $95 at MKM Partners
    04/28/21 Wedbush
    Pinterest price target lowered to $91 from $100 at Wedbush
    PINS Pinterest
    $55.49 /

    -1.635 (-2.86%)

    PINS Pinterest
    $55.49 /

    -1.635 (-2.86%)

    PINS Pinterest
    $55.49 /

    -1.635 (-2.86%)

    PINS Pinterest
    $55.49 /

    -1.635 (-2.86%)

    On The Fly
    Fly Intel: After-Hours Movers » 18:21
    05/13/21
    05/13
    18:21
    05/13/21
    18:21
    DMTK

    DermTech

    $29.25 /

    -1.63 (-5.28%)

    , HYRE

    HyreCar

    $8.92 /

    -0.71 (-7.37%)

    , DASH

    DoorDash

    $116.22 /

    +3.24 (+2.87%)

    , SWIR

    Sierra Wireless

    $13.55 /

    +0.14 (+1.04%)

    , PHAS

    PhaseBio

    $2.81 /

    -0.11 (-3.77%)

    , VVNT

    Vivint Smart Home

    $11.75 /

    +0.6 (+5.38%)

    , ABNB

    Airbnb

    $135.95 /

    -4.22 (-3.01%)

    , FSR

    Fisker

    $9.96 /

    -0.32 (-3.11%)

    , CRMD

    CorMedix

    $7.61 /

    -0.26 (-3.30%)

    , PTE

    PolarityTE

    $1.21 /

    -0.02 (-1.63%)

    , ACB

    Aurora Cannabis

    $7.33 /

    -0.38 (-4.93%)

    , ABCL

    AbCellera

    $34.80 /

    +4.03 (+13.10%)

    , AEYE

    AudioEye

    $18.04 /

    -0.04 (-0.22%)

    , EMKR

    Emcore

    $7.27 /

    +0.21 (+2.97%)

    , DIS

    Disney

    $178.11 /

    +0.26 (+0.15%)

    , NEWR

    New Relic

    $56.57 /

    -0.325 (-0.57%)

    , ALTG

    Alta Equipment Group

    $12.87 /

    -0.13 (-1.00%)

    , GDRX

    GoodRx

    $28.34 /

    -1.14 (-3.87%)

    , METX

    Meten Edtechx

    $1.29 /

    -0.09 (-6.52%)

    Check out this evening's…

    ShowHide Related Items >><<
    VVNT Vivint Smart Home
    $11.75 /

    +0.6 (+5.38%)

    SWIR Sierra Wireless
    $13.55 /

    +0.14 (+1.04%)

    PTE PolarityTE
    $1.21 /

    -0.02 (-1.63%)

    PHAS PhaseBio
    $2.81 /

    -0.11 (-3.77%)

    NEWR New Relic
    $56.57 /

    -0.325 (-0.57%)

    HYRE HyreCar
    $8.92 /

    -0.71 (-7.37%)

    GDRX GoodRx
    $28.34 /

    -1.14 (-3.87%)

    FSR Fisker
    $9.96 /

    -0.32 (-3.11%)

    EMKR Emcore
    $7.27 /

    +0.21 (+2.97%)

    DMTK DermTech
    $29.25 /

    -1.63 (-5.28%)

    DIS Disney
    $178.11 /

    +0.26 (+0.15%)

    DASH DoorDash
    $116.22 /

    +3.24 (+2.87%)

    CRMD CorMedix
    $7.61 /

    -0.26 (-3.30%)

    ALTG Alta Equipment Group
    $12.87 /

    -0.13 (-1.00%)

    AEYE AudioEye
    $18.04 /

    -0.04 (-0.22%)

    ACB Aurora Cannabis
    $7.33 /

    -0.38 (-4.93%)

    ABNB Airbnb
    $135.95 /

    -4.22 (-3.01%)

    ABCL AbCellera
    $34.80 /

    +4.03 (+13.10%)

    DMTK DermTech
    $29.25 /

    -1.63 (-5.28%)

    05/03/21
    Fly Intel: Top five analyst initiations
    05/03/21 BTIG
    DermTech initiated with a Buy at BTIG
    04/28/21 Lake Street
    DermTech study with Stanford can provide added validation, says Lake Street
    04/28/21 Craig-Hallum
    DermTech stuck in Cigna 'reimbursement limbo,' says Craig-Hallum
    HYRE HyreCar
    $8.92 /

    -0.71 (-7.37%)

    02/05/21 Lake Street
    HyreCar price target raised to $19 from $7 at Lake Street
    01/29/21 Maxim
    HyreCar price target raised to $18 from $7 at Maxim
    01/29/21 Ladenburg
    'Emerging leader' HyreCar upgraded to Buy with $17 target at Ladenburg
    01/29/21 Ladenburg
    HyreCar upgraded to Buy from Neutral at Ladenburg
    DASH DoorDash
    $116.22 /

    +3.24 (+2.87%)

    05/05/21 Cowen
    Department of Labor comments incrementally encouraging for Uber/Lyft, says Cowen
    04/26/21 Needham
    DoorDash initiated with a Buy at Needham
    04/23/21 JPMorgan
    Olo agreement with DoorDash removes litigation risk, says JPMorgan
    04/05/21 Evercore ISI
    DoorDash initiated with an In Line at Evercore ISI
    SWIR Sierra Wireless
    $13.55 /

    +0.14 (+1.04%)

    03/23/21 Roth Capital
    Roth believes IoT Services continued as ransomware impacted Sierra production
    02/24/21 BMO Capital
    Sierra Wireless price target raised to $19 from $13 at BMO Capital
    02/16/21 RBC Capital
    Sierra Wireless price target raised to $20 from $13 at RBC Capital
    02/16/21 RBC Capital
    Sierra Wireless price target raised to $20 from $13 at RBC Capital
    PHAS PhaseBio
    $2.81 /

    -0.11 (-3.77%)

    03/16/21 Needham
    PhaseBio price target raised to Street high $19 at Needham
    08/25/20 Citi
    PhaseBio price target lowered to $10 from $12 at Citi
    07/10/20 Stifel
    PhaseBio transferred with Buy rating, $11 target at Stifel
    05/29/20 Citi
    PhaseBio price target raised to $12 from $11 at Citi
    VVNT Vivint Smart Home
    $11.75 /

    +0.6 (+5.38%)

    03/11/21 Deutsche Bank
    Vivint upgraded to Buy on long-term opportunities at Deutsche Bank
    03/11/21 Deutsche Bank
    Vivint Smart Home upgraded to Buy from Hold at Deutsche Bank
    02/25/21 Deutsche Bank
    Vivint Smart Home price target lowered to $21 from $24 at Deutsche Bank
    01/15/21 Deutsche Bank
    Vivint Smart Home downgraded to Hold on valuation at Deutsche Bank
    ABNB Airbnb
    $135.95 /

    -4.22 (-3.01%)

    04/26/21 Needham
    Airbnb initiated with a Buy at Needham
    04/05/21 Evercore ISI
    Airbnb initiated with an Outperform at Evercore ISI
    03/31/21 Wolfe Research
    Airbnb assumed with a Peer Perform at Wolfe Research
    03/10/21 Citi
    Airbnb resumed with a Neutral at Citi
    FSR Fisker
    $9.96 /

    -0.32 (-3.11%)

    04/22/21
    Fly Intel: Top five analyst downgrades
    04/22/21 Goldman Sachs
    Fisker downgraded to Sell from Neutral at Goldman Sachs
    04/20/21 Morgan Stanley
    Fisker remains 'top ranked' EV related SPAC startup, says Morgan Stanley
    04/20/21 BofA
    Fisker initiated with a Buy at BofA
    CRMD CorMedix
    $7.61 /

    -0.26 (-3.30%)

    04/14/21 JMP Securities
    JMP 'confident' CorMedix has clear CRL resolution path with FDA
    03/31/21 Truist
    CorMedix price target lowered to $27 from $30 at Truist
    03/02/21 B. Riley
    CorMedix price target lowered to $13.50 from $25 at B. Riley Securities
    02/17/21 Needham
    CorMedix initiated with a Buy at Needham
    PTE PolarityTE
    $1.21 /

    -0.02 (-1.63%)

    11/19/20 Cantor Fitzgerald
    PolarityTE patent status change removes key overhang, says Cantor Fitzgerald
    ACB Aurora Cannabis
    $7.33 /

    -0.38 (-4.93%)

    05/11/21 CIBC
    Aurora Cannabis downgraded to Underperformer from Neutral at CIBC
    04/28/21 BofA
    Aurora Cannabis reinstated with a Neutral at BofA
    04/28/21 BofA
    Tilray reinstated with a Buy at BofA
    04/05/21 CIBC
    Aurora Cannabis price target lowered to C$15 from C$18.50 at CIBC
    ABCL AbCellera
    $34.80 /

    +4.03 (+13.10%)

    03/30/21 SVB Leerink
    AbCellera price target lowered to $45 from $52 at SVB Leerink
    03/24/21 BMO Capital
    AbCellera price target lowered to $59 from $61 at BMO Capital
    02/08/21 SVB Leerink
    AbCellera price target raised to $52 from $45 at SVB Leerink
    01/26/21 Berenberg
    Eli Lilly data 'incrementally positive' for AbCellera, says Berenberg
    AEYE AudioEye
    $18.04 /

    -0.04 (-0.22%)

    03/02/21 Maxim
    AudioEye price target raised to $42 from $36 at Maxim
    02/08/21 Maxim
    AudioEye initiated with a Buy at Maxim
    01/08/21 B. Riley
    AudioEye price target raised to $32 from $25 at B. Riley Securities
    09/01/20 B. Riley
    AudioEye price target raised to $25 from $21 at B. Riley FBR
    EMKR Emcore
    $7.27 /

    +0.21 (+2.97%)

    03/04/21
    Fly Intel: Top five analyst initiations
    03/04/21 Craig-Hallum
    Craig-Hallum bullish on Emcore, initiates with a Buy
    03/04/21 Craig-Hallum
    Emcore initiated with a Buy at Craig-Hallum
    10/26/20 Northland
    Northland upgrades Applied Optoelectronics to Market Perform on cable outlook
    DIS Disney
    $178.11 /

    +0.26 (+0.15%)

    05/12/21 Morgan Stanley
    Disney price target raised to $210 from $200 at Morgan Stanley
    05/10/21 Evercore ISI
    American Campus upgraded to Outperform at Evercore ISI on faster Disney ramp
    05/03/21 BofA
    BofA adds Disney and Avalara, removes Comcast and Netflix from U.S. 1 List
    04/26/21 Truist
    Disney could be beneficiary if Roku stops carrying YouTube TV, says Truist
    NEWR New Relic
    $56.57 /

    -0.325 (-0.57%)

    02/05/21
    Fly Intel: Top five analyst downgrades
    02/05/21 Raymond James
    New Relic downgraded to Market Perform from Strong Buy at Raymond James
    02/05/21 Loop Capital
    New Relic price target raised to $70 from $60 at Loop Capital
    02/05/21 BMO Capital
    New Relic price target raised to $71 from $64 at BMO Capital
    ALTG Alta Equipment Group
    $12.87 /

    -0.13 (-1.00%)

    03/22/21 DA Davidson
    Alta Equipment Group price target raised to $16 from $14 at DA Davidson
    03/19/21 B. Riley
    Alta Equipment Group price target raised to $17 from $16 at B. Riley
    03/11/21 DA Davidson
    Alta Equipment Group initiated with a Buy at DA Davidson
    01/07/21 B. Riley
    Alta Equipment Group price target raised to $16 from $15 at B. Riley Securities
    GDRX GoodRx
    $28.34 /

    -1.14 (-3.87%)

    05/12/21 SVB Leerink
    GoodRx moat still intact as Amazon Pharmacy push continues, says SVB Leerink
    05/10/21 Cowen
    GoodRx price target lowered to $58 from $70 at Cowen
    04/05/21 Evercore ISI
    GoodRx assumed with an Outperform at Evercore ISI
    03/12/21 Barclays
    GoodRx price target raised to $43 from $35 at Barclays
    METX Meten Edtechx
    $1.29 /

    -0.09 (-6.52%)

    VVNT Vivint Smart Home
    $11.75 /

    +0.6 (+5.38%)

    SWIR Sierra Wireless
    $13.55 /

    +0.14 (+1.04%)

    PTE PolarityTE
    $1.21 /

    -0.02 (-1.63%)

    PHAS PhaseBio
    $2.81 /

    -0.11 (-3.77%)

    NEWR New Relic
    $56.57 /

    -0.325 (-0.57%)

    HYRE HyreCar
    $8.92 /

    -0.71 (-7.37%)

    GDRX GoodRx
    $28.34 /

    -1.14 (-3.87%)

    FSR Fisker
    $9.96 /

    -0.32 (-3.11%)

    EMKR Emcore
    $7.27 /

    +0.21 (+2.97%)

    DMTK DermTech
    $29.25 /

    -1.63 (-5.28%)

    DIS Disney
    $178.11 /

    +0.26 (+0.15%)

    DASH DoorDash
    $116.22 /

    +3.24 (+2.87%)

    CRMD CorMedix
    $7.61 /

    -0.26 (-3.30%)

    ALTG Alta Equipment Group
    $12.87 /

    -0.13 (-1.00%)

    AEYE AudioEye
    $18.04 /

    -0.04 (-0.22%)

    ACB Aurora Cannabis
    $7.33 /

    -0.38 (-4.93%)

    ABNB Airbnb
    $135.95 /

    -4.22 (-3.01%)

    ABCL AbCellera
    $34.80 /

    +4.03 (+13.10%)

    • 18
      Mar
    • 11
      Feb
    • 04
      Feb
    • 22
      Jan
    • 07
      Jan
    • 11
      Dec
    • 10
      Dec
    • 09
      Dec
    • 11
      Nov
    • 23
      Sep
    • 27
      Aug
    • 28
      Jul
    GDRX GoodRx
    $28.34 /

    -1.14 (-3.87%)

    FSR Fisker
    $9.96 /

    -0.32 (-3.11%)

    DMTK DermTech
    $29.25 /

    -1.63 (-5.28%)

    DIS Disney
    $178.11 /

    +0.26 (+0.15%)

    DASH DoorDash
    $116.22 /

    +3.24 (+2.87%)

    ACB Aurora Cannabis
    $7.33 /

    -0.38 (-4.93%)

    ABNB Airbnb
    $135.95 /

    -4.22 (-3.01%)

    SWIR Sierra Wireless
    $13.55 /

    +0.14 (+1.04%)

    PTE PolarityTE
    $1.21 /

    -0.02 (-1.63%)

    NEWR New Relic
    $56.57 /

    -0.325 (-0.57%)

    HYRE HyreCar
    $8.92 /

    -0.71 (-7.37%)

    GDRX GoodRx
    $28.34 /

    -1.14 (-3.87%)

    FSR Fisker
    $9.96 /

    -0.32 (-3.11%)

    DMTK DermTech
    $29.25 /

    -1.63 (-5.28%)

    DIS Disney
    $178.11 /

    +0.26 (+0.15%)

    DASH DoorDash
    $116.22 /

    +3.24 (+2.87%)

    ACB Aurora Cannabis
    $7.33 /

    -0.38 (-4.93%)

    ABNB Airbnb
    $135.95 /

    -4.22 (-3.01%)

    ABCL AbCellera
    $34.80 /

    +4.03 (+13.10%)

    PTE PolarityTE
    $1.21 /

    -0.02 (-1.63%)

    GDRX GoodRx
    $28.34 /

    -1.14 (-3.87%)

    FSR Fisker
    $9.96 /

    -0.32 (-3.11%)

    EMKR Emcore
    $7.27 /

    +0.21 (+2.97%)

    DMTK DermTech
    $29.25 /

    -1.63 (-5.28%)

    DIS Disney
    $178.11 /

    +0.26 (+0.15%)

    DASH DoorDash
    $116.22 /

    +3.24 (+2.87%)

    ACB Aurora Cannabis
    $7.33 /

    -0.38 (-4.93%)

    ABNB Airbnb
    $135.95 /

    -4.22 (-3.01%)

    ABCL AbCellera
    $34.80 /

    +4.03 (+13.10%)

    Hot Stocks
    Twitter brings DM search bar to Android » 18:17
    05/13/21
    05/13
    18:17
    05/13/21
    18:17
    TWTR

    Twitter

    $50.11 /

    -0.6 (-1.18%)

    , GOOG

    Alphabet

    $2,261.45 /

    +21.72 (+0.97%)

    , GOOGL

    Alphabet Class A

    $2,228.54 /

    +27.21 (+1.24%)

    Twitter (TWTR) announced…

    Twitter (TWTR) announced that it has brought the direct message, or DM, search bar to Android (GOOG) and is rolling out an improved version that lets users search for all of their old conversations, not just the most recent ones. "Waiting for the option to search your DMs for message content? We're working on releasing that later this year!" Twitter added. Reference Link

    ShowHide Related Items >><<
    TWTR Twitter
    $50.11 /

    -0.6 (-1.18%)

    GOOGL Alphabet Class A
    $2,228.54 /

    +27.21 (+1.24%)

    GOOG Alphabet
    $2,261.45 /

    +21.72 (+0.97%)

    TWTR Twitter
    $50.11 /

    -0.6 (-1.18%)

    05/10/21 Citi
    Twitter price target lowered to $58 from $80 at Citi
    05/03/21 BMO Capital
    Twitter price target lowered to $65 from $80 at BMO Capital
    04/30/21 MKM Partners
    Twitter price target lowered to $83 from $95 at MKM Partners
    04/30/21 JPMorgan
    Twitter earnings selloff a buying opportunity, says JPMorgan
    GOOG Alphabet
    $2,261.45 /

    +21.72 (+0.97%)

    05/10/21
    Fly Intel: Top five analyst downgrades
    05/10/21 Citi
    Citi downgrades Google and Facebook on bullish sell-side expectations
    05/10/21 Citi
    Facebook downgraded at Citi with Google on concerns over expectations
    05/03/21
    Fly Intel: Top five analyst upgrades
    GOOGL Alphabet Class A
    $2,228.54 /

    +27.21 (+1.24%)

    05/10/21 Citi
    ViacomCBS added, Google removed from Citi's Recommended List
    TWTR Twitter
    $50.11 /

    -0.6 (-1.18%)

    GOOG Alphabet
    $2,261.45 /

    +21.72 (+0.97%)

    TWTR Twitter
    $50.11 /

    -0.6 (-1.18%)

    GOOG Alphabet
    $2,261.45 /

    +21.72 (+0.97%)

    TWTR Twitter
    $50.11 /

    -0.6 (-1.18%)

    GOOG Alphabet
    $2,261.45 /

    +21.72 (+0.97%)

    TWTR Twitter
    $50.11 /

    -0.6 (-1.18%)

    GOOGL Alphabet Class A
    $2,228.54 /

    +27.21 (+1.24%)

    GOOG Alphabet
    $2,261.45 /

    +21.72 (+0.97%)

    Initiation
    Live Nation initiated with an Outperform at Wolfe Research » 17:53
    05/13/21
    05/13
    17:53
    05/13/21
    17:53
    LYV

    Live Nation

    $81.25 /

    +3.31 (+4.25%)

    Wolfe Research analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    LYV Live Nation
    $81.25 /

    +3.31 (+4.25%)

    LYV Live Nation
    $81.25 /

    +3.31 (+4.25%)

    05/10/21
    Fly Intel: Top five analyst upgrades
    05/10/21 Jefferies
    Live Nation upgraded to Buy following 13% pullback at Jefferies
    05/10/21 Jefferies
    Live Nation upgraded to Buy from Hold at Jefferies
    02/26/21 Cowen
    Live Nation price target raised to $100 from $85 at Cowen
    LYV Live Nation
    $81.25 /

    +3.31 (+4.25%)

    LYV Live Nation
    $81.25 /

    +3.31 (+4.25%)

    LYV Live Nation
    $81.25 /

    +3.31 (+4.25%)

    LYV Live Nation
    $81.25 /

    +3.31 (+4.25%)

    Earnings
    ProPhase Labs reports Q1 EPS 7c, consensus 20c » 17:46
    05/13/21
    05/13
    17:46
    05/13/21
    17:46
    PRPH

    ProPhase Labs

    $5.60 /

    +0.25 (+4.67%)

    Reports Q1 revenue…

    Reports Q1 revenue $15.3M, consensus $11.98M. "Q1 marked our first full quarter processing COVID-19 and Respiratory Pathogen Panel Molecular tests, processing just under 2,000 tests per day," said CEO Ted Karkus. "(...) Our pipeline of RFPs is expanding, and we hope to see more wins in the coming months with the potential for higher margin accounts. Leveraging the success of our business strategy pivot in November 2020, we continue to evaluate accretive acquisitions and/or licensing opportunities. In particular, we are working on the development and licensing of antigen and immunity tests to complement our PCR testing as part of our initial diversification strategy. We see significant market potential for these tests, given the devastating impact of COVID-19. Outside of COVID-19 testing, we also see CLIA lab acquisition opportunities in blood, urine, toxicology and pathology that we believe will position our CLIA labs with full-service testing options. (...) We expect our financial position will begin to benefit from the transition from the development phase for ProPhase Diagnostics to revenue growth, along with our continued focus on our contract manufacturing and dietary supplement businesses. (...) We believe we have ample working capital for all of our current and projected needs related to the build out of our CLIA lab testing services, as well as the pursuit of additional CLIA labs that will diversify our testing services, either by acquisition or by building an additional facility, or both".

    ShowHide Related Items >><<
    PRPH ProPhase Labs
    $5.60 /

    +0.25 (+4.67%)

    PRPH ProPhase Labs
    $5.60 /

    +0.25 (+4.67%)

    01/20/21 Dawson James
    ProPhase Labs initiated with a Buy at Dawson James
    PRPH ProPhase Labs
    $5.60 /

    +0.25 (+4.67%)

    PRPH ProPhase Labs
    $5.60 /

    +0.25 (+4.67%)

    PRPH ProPhase Labs
    $5.60 /

    +0.25 (+4.67%)

    Conference/Events
    Jones Lang LaSalle to host virtual investor meeting » 17:45
    05/13/21
    05/13
    17:45
    05/13/21
    17:45
    JLL

    Jones Lang LaSalle

    $199.11 /

    +1.08 (+0.55%)

    Virtual Investor meeting…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    JLL Jones Lang LaSalle
    $199.11 /

    +1.08 (+0.55%)

    JLL Jones Lang LaSalle
    $199.11 /

    +1.08 (+0.55%)

    05/06/21 JPMorgan
    Jones Lang LaSalle price target raised to $219 from $200 at JPMorgan
    02/26/21 JPMorgan
    Jones Lang LaSalle price target raised to $200 from $176 at JPMorgan
    01/25/21 Goldman Sachs
    Jones Lang LaSalle initiated with a Buy at Goldman Sachs
    12/21/20 JPMorgan
    Jones Lang LaSalle price target raised to $172 from $132 at JPMorgan
    JLL Jones Lang LaSalle
    $199.11 /

    +1.08 (+0.55%)

    JLL Jones Lang LaSalle
    $199.11 /

    +1.08 (+0.55%)

    Hot Stocks
    ProPhase Labs announces special cash dividend of 30c per share » 17:44
    05/13/21
    05/13
    17:44
    05/13/21
    17:44
    PRPH

    ProPhase Labs

    $5.60 /

    +0.25 (+4.67%)

    The dividend is payable…

    The dividend is payable on June 3 to stockholders of record as of May 25.

    ShowHide Related Items >><<
    PRPH ProPhase Labs
    $5.60 /

    +0.25 (+4.67%)

    PRPH ProPhase Labs
    $5.60 /

    +0.25 (+4.67%)

    01/20/21 Dawson James
    ProPhase Labs initiated with a Buy at Dawson James
    PRPH ProPhase Labs
    $5.60 /

    +0.25 (+4.67%)

    PRPH ProPhase Labs
    $5.60 /

    +0.25 (+4.67%)

    PRPH ProPhase Labs
    $5.60 /

    +0.25 (+4.67%)

    Periodicals
    Valero granted Jones Act waiver following Colonial outage, Reuters reports » 17:36
    05/13/21
    05/13
    17:36
    05/13/21
    17:36
    VLO

    Valero

    $78.52 /

    -1.48 (-1.85%)

    , MPC

    Marathon Petroleum

    $58.79 /

    -0.18 (-0.31%)

    After a cyberattack shut…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    VLO Valero
    $78.52 /

    -1.48 (-1.85%)

    MPC Marathon Petroleum
    $58.79 /

    -0.18 (-0.31%)

    VLO Valero
    $78.52 /

    -1.48 (-1.85%)

    05/03/21 Citi
    Citi adds Valero to US Focus List, boosts target to $121
    04/27/21 RBC Capital
    Valero price target raised to $94 from $82 at RBC Capital
    04/16/21 Raymond James
    Valero upgraded to Strong Buy from Outperform at Raymond James
    04/16/21 Raymond James
    Valero upgraded to Strong Buy from Outperform at Raymond James
    MPC Marathon Petroleum
    $58.79 /

    -0.18 (-0.31%)

    05/05/21 RBC Capital
    Marathon Petroleum price target raised to $70 from $60 at RBC Capital
    04/16/21 Raymond James
    Marathon Petroleum double upgraded to Strong Buy at Raymond James
    04/16/21 Raymond James
    Marathon Petroleum upgraded to Strong Buy from Market Perform at Raymond James
    04/01/21 Piper Sandler
    Marathon Petroleum price target raised to $60 from $50 at Piper Sandler
    VLO Valero
    $78.52 /

    -1.48 (-1.85%)

    MPC Marathon Petroleum
    $58.79 /

    -0.18 (-0.31%)

    VLO Valero
    $78.52 /

    -1.48 (-1.85%)

    VLO Valero
    $78.52 /

    -1.48 (-1.85%)

    VLO Valero
    $78.52 /

    -1.48 (-1.85%)

    MPC Marathon Petroleum
    $58.79 /

    -0.18 (-0.31%)

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.